Self-engineered iron oxide nanoparticle incorporated on mesoporous biochar derived from textile mill sludge for the removal of an emerging pharmaceutical pollutant

In the present work, low-cost and efficient iron oxide nanoparticle incorporated on mesoporous biochar was prepared from effluent treatment plant (ETP) sludge collected from the textile industry. This sludge contains a higher amount of Fe due to the use of ferric chloride as a coagulant in the treatment of wastewater generated during the process. The raw sludge and prepared biochar was extensively examined by various sophisticated techniques like XRF, XRD, BET, TGA, XPS, RAMAN, FTIR, FESEM, TEM, and VSM. TEM and XRD analysis confirms the presence of iron oxide nanoparticles on mesoporous biochar. The prepared biochar was found to possess BET surface area of 91 m(2) g(-1). Several parameters like pH, dose, initial concentration, temperature and time were optimized for the adsorptive removal of ofloxacin (OFL) from aqueous solution. Biochar (named as BTSFe) achieved approximate to 96% removal efficiency of OFL with a maximum adsorption capacity (q(m)) of 19.74 mg g(-1) at optimum condition. pi-pi electron-donor-acceptor and H bonding were the major mechanisms responsible for the OFL adsorption. Kinetic and equilibrium thermodynamic study of showed that the adsorption of OFL was represented by the pseudo-second-order kinetics model, and the process was exothermic and spontaneous. Additionally, Redlich-Peterson and Freundlich isotherms best fitted the experimental data indicating multilayer adsorption phenomenon. Biochar was magnetically separated and thermally regenerated after each cycle for five times with a nominal overall decrease of approximate to 8% in removal efficiency. Leaching of iron during the adsorption process was also checked and found to be within the permissible limit. This study provides an alternative application of the textile industry sludge as an efficient, low-cost biochar for the removal of emerging pharmaceutical compounds. (C) 2019 Elsevier Ltd. All rights reserved.